Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RASBURICASE vs REGADENOSON: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RASBURICASE vs REGADENOSON: Safety Overview

Metric RASBURICASE REGADENOSON
Total FAERS Reports 885 3,071
Deaths Reported 167 84
Death Rate 18.9% 2.7%
Hospitalizations 412 321
Average Patient Age 51.8 yrs 68.1 yrs
% Female Patients 36.3% 58.6%
FDA Approval Date N/A Apr 10, 2008
Manufacturer Sanofi-Aventis U.S. LLC Apotex Corp.
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription